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1. Introduction 
Sensorineural hearing loss is a major public health problem affecting more than 278 million 
people worldwide.  The primary cause of sensorineural hearing loss is loss or damage of 
sensory hair cells in the organ of Corti.  However, approximately 10-15% of cases with 
profound hearing loss in children are caused by degeneration of the spiral ganglion neurons 
(SGNs) or neurons in the auditory brainstem.  Moreover, SGNs gradually degenerate after 
the loss of hair cells due to a lack of excitatory stimulation.  Since SGNs do not regenerate to 
any clinically significant extent, novel therapies for their preservation, regeneration or 
replacement are being heavily sought.  Currently, no treatment option is available for 
peripheral auditory neuropathy.   
Cell-based therapies offer a strategy to enhance auditory functions in the deaf patient and 
improve the benefits of cochlear implantation.  There are three major areas for potential 
clinical applications relevant to this approach.  First, for patients who have received cochlear 
implants, generation or preservation of SGNs via cell replacement therapy could 
significantly improve the quality of their sound perception.  Another group of potential 
recipients who would benefit from cell replacement therapy are patients suffering from 
acoustic neuroma or neurofibromatosis.  These patients generally exhibit significant loss of 
auditory or vestibular primary neurons with relatively intact sensory hair cells (Kaga et al., 
1997; Evans et al., 2000; Sperfeld et al., 2002).  Thus, replacing dead or damaged neurons 
with stem cells could be critical in restoring their hearing or balance sensation.  Finally, 
auditory neurons generated from stem cells could be used in in vitro assays to test the 
effectiveness and safety of newly developed drugs before clinical trials. 
Type I SGNs, comprising 95% of all neural populations in the SG, innervate inner hair cells 
in the organ of Corti and function as the primary auditory afferent neurons (Berglund and 
Ryugo, 1987; Liberman et al., 1990; Rusznak and Szucs, 2009).  These SGNs predominantly 
express AMPA receptors (mainly GluR2-4) (Niedzielski and Wenthold, 1995; Parks, 2000; 
Dulon et al., 2006; Chen et al., 2007; Flores-Otero et al., 2007), which bind the 
neurotransmitter glutamate released from inner hair cells (Fig. 1).  This subsequently 
triggers action potentials that propagate along the nerve fibers to the cochlear nucleus.  The 
majority, if not all, of type I SGNs are glutamatergic and release glutamate from their pre-
synaptic membrane in the cochlear nucleus (Rebillard et al., 2003; Reyes et al., 2008).  
Expression of AMPA receptors and glutamate transporters thus is the hallmark of mature 
type I SGNs. During embryonic development, SGNs arise from the otic placode and 
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transiently express several key transcription factors, including Neurogenin 1 (Ngn1), 
NeuroD and Brn3a (Fig. 3).  Inactivation of these transcription factors results in a significant 
reduction in the number of SGNs or severe retardation in the axon projections to the cochlea 
(Ma et al., 1998; Huang et al., 2001; Kim et al., 2001). Thus, Ngn1, NeuroD and Brn3a 
represent phenotypic markers for immature SGNs. 
Over the past several years, progress has been made to generate in vitro functional neurons 
bearing a SGN phenotype from embryonic stem cells and different types of somatic stem 
cells (Martinez-Monedero et al., 2008; Reyes et al., 2008; Chen et al., 2009).  Some of these 
stem cell-derived neurons were shown to establish synaptic contacts with sensory hair cells, 
the peripheral target for SGNs, in vitro (Matsumoto et al., 2008) and to survive in animals 
with selective loss of SGNs (Corrales et al., 2006; Matsuoka et al., 2007).  However, little 
information is currently available how to promote pluripotent stem cells competent to give 
rise exclusively to glutamatergic sensory neurons. 
 
 
Fig. 1. Glutamate is a primary afferent neurotransmitter in the cochlea 
2. Embryonic stem cells can be efficiently directed to differentiate into 
neurons in vitro 
We have established an efficient feeder-cell free neural induction protocol based on a 
previous study (Watanabe et al., 2005) and, using this protocol, extensively characterized 
temporal changes in gene expression in ESCs undergoing neural differentiation.  Briefly, 
undifferentiated mouse R1 ESCs were dissociated and cultured in bacteria plates to allow 
embryoid body (EB) formation, after which EBs were plated on tissue culture plates and 
cultured in a pre-induction medium (Step 1).  After 2 days, the medium was changed to a 
neural induction medium and maintained for an additional 1-15 days (Step 2).  During the 
first differentiation, EBs became larger in size, but there was no indication of neurite-like 
processes.  Only one day after the start of the second step, cells in the outer edge emigrated 
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from the EB (Fig. 2A).  Three days after the start of neural induction, numerous neurite 
processes emerged from the outer edge of EBs.  At 7 days after the start of neural induction, 
much denser and longer processes than those seen at 3 days of neural induction were 
observed in EBs.  At 15 days after the start of neural induction, processes remained dense 
and they appeared to extend to other EBs to make contacts.  Immunohistochemical staining 
for HuC and TuJ1, specific neuronal markers, indicated that the cells bearing neurite-like 
processes were indeed neurons.  Morphological changes in ES cells during neural induction, 
characterized by growth of neurite processes, were progressive in the first 7 days, after 
which they remained largely unchanged until the last day of 15 day neural induction. 
 
 
Fig. 2. (A) Morphological changes in ESCs undergoing neural differentiation.  TUJ1 and 
HuC, neuron-specific proteins, are detected in a subpopulation of cells suggesting a 
neuronal fate.  TUJ1 accumulates in the axon-like processes, while HuC is restricted to the 
cell body consistent with its function as a translation factor.  (B) RT-PCR analysis for ESC- 
and neural-marker genes in undifferentiated ESCs (ESC), ESCs at EB stage (day 5), 3d, 7d, 
10d, and 15d after start of neural induction (NI-3, -7, -10 and -15,  respectively) 
To evaluate temporal changes in gene expression, qRT-PCR analyses were performed with 
RNAs collected from ESCs or ESC-derived cells at various time points during 
differentiation.  The results demonstrated steep reductions of ESC-specific genes, including 
Oct4, Rex1 and Sox2, in contrast with rapid (early neural genes: Musashi1 and HuC) or 
gradual (mature neural genes: TUJ1, NSE, Synaptophysin, Calretinin, TrkB and Tau) increases 
of neural marker genes (Fig. 2B).  Results from our Western blot analysis for the 
corresponding proteins were consistent with the qRT-PCR results with delayed peaks of 
about 3 days (Kondo et al., 2008).  Down-regulation of Oct4 and Sox2 was accompanied by 
transient up-regulation of early neural marker proteins, including Musashi1 and HuC, 
which was followed by stable induction of mature neural proteins, including TUJ1, 
Calretinin, Synaptophysin, NSE and Tau.  To evaluate the percentage of ESC-derived cells 
exhibiting neural cell surface markers during neural differentiation, we performed flow 
cytometric analyses for CD24 and Tau.  Virtually none of undifferentiated ESCs express CD 
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24 or Tau, while over 90% of those are positive for both neural markers at neural induction 
day 7 (Kondo et al., 2008).  To assess electrophysiological properties of induced ESC-derived 
cells, we performed single-cell current-clamp recordings.  Robust action potentials and 
voltage-dependent inward sodium currents were recorded from ≈70% of ESC-derived cells 
at neural induction day 7 (Kondo et al., 2008).     
3. Tlx3 promotes glutamatergic neuronal specification and is a direct target 
for Wnt signaling 
We have previously demonstrated that T cell leukemia 3 (Tlx3; also known as Hox11-
L2/Rnx) can be used as a potent intrinsic factor to generate, from mouse ESCs, excitatory 
neurons with a phenotype that resembles type I SGNs (Kondo et al., 2008).  Tlx3 is a 
member of the Tlx family of homeobox transcription factors and is selectively expressed in 
cranial and dorsal root sensory ganglia, including SGNs, during early embryogenesis 
(Logan et al., 1998; Cheng et al., 2004; Cheng et al., 2005; Kondo et al., 2008).  Tlx3 is a 
genetic switch for selection of a glutamatergic over a GABAergic transmitter phenotype 
during nervous system development (Cheng et al., 2004; Cheng et al., 2005; Xu et al., 2008).  
We have found that forced expression of Tlx3 in ESCs combined with directed neural 
induction leads to sequential up-regulation of genes (and proteins) that are expressed in 
transiently-amplifying neural progenitors (Mash1), immature (Ngn1, NeuroD, Brn3a) and 
mature (GluR2, GluR4, Vglut2) SGNs (Kondo et al., 2008).  Furthermore, these Tlx3-
expressing ESC-derived neurons exhibited robust action potentials and excitatory post-
synaptic currents, indicative of functional excitatory neurons. 
 
 
Fig. 3. (A) Sequential expression of Ngn1, NeuroD and Brn3a during SGN development. (B) 
Temporal changes in gene expression during inner ear development.  C; cochlea, V; 
vestibule 
Since Tlx3 is a transcription factor, we sought to identify a signaling molecule that controls 
Tlx3 expression with the ultimate goal of developing a means to extrinsically induce 
glutamatergic neuronal specification from ESCs (Kondo et al., submitted). Wnt/β-catenin 
signaling promotes neural differentiation by activation of the neuron-specific transcription 
factors, Ngn1, NeuroD and Brn3a, during neural development.  The canonical Wnt pathway 
activation allows β-catenin to translocate to the nucleus, where it interacts with the T-cell 
factor (TCF) family of DNA-binding proteins and β-catenin/TCF complexes regulate 
transcription (Fig. 4). Based on this consensus signaling pathway, the β-catenin/TCF 
complexes are the prime nuclear effectors for canonical Wnt signaling. Since neurons in 
cranial sensory ganglia and dorsal root ganglia transiently express Ngn1, NeuroD and Brn3a 
during embryonic development, we hypothesized that Wnt(s) could instructively promote a 
sensory neuronal fate from stem cells undergoing neural induction.  Consistent with our 
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hypothesis, Wnt1 induced expression of sensory neuron marker genes, including Ngn1, 
NeuroD, Brn3a and P2X3, as well as glutamatergic marker genes, such as GluR2 and GluR4, 
in neurally-induced somatic stem cells in a dose-dependent manner (Fig. 4; Kondo et al., 
submitted). Additionally, Wnt1-induced up-regulation of these genes was suppressed by 
specific canonical Wnt antagonists, Dickkopf-related protein 1 (Dkk1) and Secreted frizzled-
related protein 2 (sFRP2). The inhibitory effects of Dkk1 and sFRP2 were specific, as they 
had no effects on expression levels of GATA3, Tau and TUJ1, none of which is regulated by 
Wnt1. Furthermore, expression levels of Brn3a, GluR2, GluR4 and Vglut2 proteins in 
neurally induced stem cells grown in the presence of Wnt1 were significantly higher than 
those grown in the absence of Wnt1, indicating that Wnt1 up-regulates glutamatergic 
sensory neuron-specific proteins in neurally-competent stem cells. 
 
 
Fig. 4. Schematic figure showing canonical Wnt signaling pathway and our results 
Given the consensus function of Tlx3 as a glutamatergic selector gene, we postulated that 
the effects of canonical Wnt signaling on sensory neuron and glutamatergic marker 
expression in stem cells may be mediated by Tlx3.  We first confirmed that Wnt1 can indeed 
up-regulate Tlx3 expression in somatic stem cells and the Wnt1-induced Tlx3 up-regulation 
was entirely suppressed by Dkk1 or sFRP2 (Fig. 4; Kondo et al., submitted). Next, we 
demonstrated that forced expression of Tlx3 induced sensory and glutamatergic neuron 
markers after neural induction. Moreover, our chromatin immunoprecipitation assays 
revealed that TCF3/4 directly bind a regulatory region of Tlx3 after neural induction 
(Kondo et al., submitted).  To further characterize this binding site, we have cloned 2600 bp 
5’- and 1700 bp 3’-non-coding regions flanking the Tlx3 coding region into a luciferase 
reporter vector and generated another reporter construct with a mutation in the TCF 
binding motif (Fig. 5A). Wild-type ESCs were transfected with a reporter construct 
containing the luciferase gene under the control of the wild-type or mutant Tlx3 promoter and 
a constitutively expressing the Renilla luciferase construct  for normalization of transfection 
efficiency. Transfected cells were incubated in neural induction medium in the presence or 
absence of 100 ng/mL Wnt1 for 2 days and luciferase activities were analyzed using a Dual 
Luciferase Reporter Assay System. Consistent with our hypothesis, the Wnt1-induced Tlx3 
promoter activity was significantly reduced with a mutation in the region 3 TCF binding site, 
when compared to a wild-type (Fig. 5B).  These results demonstrate that the TCF binding site 
in the Tlx3 promoter is required for Wnt-dependent transactivation of Tlx3. 
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Fig. 5. Luciferase reporter activity of ESCs transfected with the empty vector (pGL3), wild-
type or mutant Tlx3 reporter construct 
4. ESC-derived neurons expressing Tlx3 form growth cones enriched with 
GAP43 
We have characterized molecular and biochemical properties of Tlx3-expressing ESCs 
undergoing neural differentiation and found that Tlx3 instructively promotes these stem 
cells to acquire a glutamatergic phenotype, while suppressing a GABAergic phenotype 
(Kondo et al., 2008). To determine whether these Tlx3-expressing cells exhibit functional 
characteristics of excitatory glutamatergic neurons and make synaptic contacts with their 
targets after neural induction, we have performed subcellular fractionation and obtained 
evidence that ESC-derived neurons expressing Tlx3 form growth cones that are enriched 
with GAP43. Similar to primary neurons in vitro, GAP43 was co-localized with 
neurofilament 160 as well as F-actin in the distal tip of ESC-derived neurons at neural 
induction day 7 (Fig. 6A).  Western blot analysis of whole cell lysates revealed that GAP43, 
Tau and the pan-sodium channel protein SP19 are abundant in ESC-derived neurons, but 
that none of these proteins was detectable in undifferentiated ESCs or EBs (Fig. 6B). To 
elucidate sub-cellular localization of GAP43, we isolated an enriched population of growth 
cone particles using a discontinuous density gradient sucrose (Fig. 6C). Our 
immunoprecipitation and western blot analyses detected a substantially higher GAP43 
expression in the growth cone particle fraction (0.32/0.83M) when compared to whole lysate 
(before isolation) or the non-growth cone fraction (1.20/2.66M) (Fig. 6D). These results 
indicate that GAP43 is enriched in the growth cone of ESC-derived neurons expressing Tlx3 
and suggest that the growth cone assembly, which is essential for axon guidance and target 
innervation,  is already in place in these ESC-derived cells by neural induction day 7. 
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Fig. 6. GAP43 is enriched in growth cones of ESC-derived neurons expressing Tlx3.  (A) 
Expression of GAP43 (red), Neurofilament 160 (blue) and F-actin (green) at neural induction 
day 7.  (B) Western blot analysis for GAP43, Tau and SP19.  ESC: undifferentiated ESCs; EB: 
embryoid bodies; NI: ESC-derived cells at neural induction day 7; B: brain (positive control).  
(C) Isolation of growth cone particle (GCP) fractions.  (D) Immunoprecipitation and western 
blot analysis for GAP43 in GCP vs. non-GCP fractions 
5. Tlx3-expressing ESC-derived neurons are attracted to hair cells in the 
cochlea 
To study interactions between Tlx3-expressing ESC-derived neurons and embryonic inner ear 
tissues, GFP-positive ESCs were co-cultured with an E18 mouse organ of Corti, the peripheral 
target tissue for SGNs (Fig. 7). Organ of Corti tissues were removed from E18 mice and 
embedded into rat type I collagen in 8-chamber slide wells. Cochlear tissues were removed 
from wild-type E18 mice and embedded into rat type I collagen. Four to five hours after the 
start of incubation, Tlx3-expressing ESCs forming spheres were placed into collagen 
approximately 100 µm in the distance from a cochlear explant. On the following day, the 
medium was replaced with neural induction medium and incubation continued for an 
additional 5 days. In the presence of an organ of Corti explant, Tlx3-expressing ESCs survived 
and propagated vigorously, but upon exposure to the neural induction medium, withdrew 
from the cell cycle and differentiated into neurons. Additionally, these ESC-derived cells 
began expressing sensory neuron-specific antigens, such as GluR4 and calretinin, along with 
several pan-neuronal markers.  Furthermore, ESC-derived neurons extended their processes 
towards the explant, formed ectopic synaptic contacts with cells in the organ of Corti. 
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Fig. 7. (A, B) Tlx3-expressing ESC-derived neurons are attracted to both embryonic cochlea 
and auditory brain stem.  Low-magnification fluorescence photo micrographs of 3-D 
collagen cultures with GFP-positive ESC-derived neurons and an E18 cochlear explant (A) 
or a brainstem slice (B). (A) MyosinVII (Red) and TUJ1 (Purple) immunoflorescence.   Note 
that GFP-positive processes from ESC-derived neurons are extended towards the cochlear 
explants.  CO, cochlear explant.  (B) Mafb (Red) and GAP43 (Purple) immunofluorescence 
6. Tlx3-expressing ESCs can survive and migrate towards endogenous SGNs 
in animal model of auditory neuropathy 
We transplanted partially differentiated ESCs into the modiolus of the deafened gerbil 
cochlea that subsequently received neural induction medium for 3 days via osmotic pumps.  
Four-to-six month-old Mongolian gerbils were used as transplantation recipients.  To deafen 
the animals, focal application of ouabain was performed based on a previously described 
procedure (Matsuoka et al., 2007) with minor modifications. Briefly, the animals, free of any 
signs of ear infection, were given atropine (0.2 mg/kg) to reduce secretion prior to the 
surgery.  Following anesthesia with isoflurane, a small incision (less than 1.5 cm) was made 
to expose the right posterior aspect of the skull.  A total volume of 5 µL ouabain solution (1 
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mM in normal saline) was slowly infused into the round window niche using a siliconized 
glass micropipette attached to a 10 µL Hamilton syringe. A small piece of gelform was 
placed in the round window niche to prevent leaking of excessive ouabain.  The same 
amount of normal saline was infused into the left cochlea of the animal, which served as a 
control.  Ouabain was washed off after 1 hour, the bulla will be closed with dental cement 
(Durelon, 3M ESPE), and a two-layer closure was made in the skin.  The animals were allowed 
to recover for 4 weeks, during which progressive degeneration of spiral ganglion neurons took 
place. At the end of the recovery period, animals received a modiolar transplantation of ESCs 
stably expressing pBud-eGFP-cTlx3. Under anesthesia, a small fenestra was made in the wall 
of the basal turn scala tympani and a suspension of Tlx3-expressing stem cells (1x106 cells/μL) 
in 10 μL PBS (left ear) through a 30-gauge needle that was inserted into the bony wall of the 
basal turn of the gerbil cochlea. 
 
 
Fig. 8. Low (A) and high (B)-magnification micrographs of GFP-positive ESCs transplanted 
into the modiolus of the gerbil cochlea that has received neural induction medium. SG, 
spiral ganglion 
We observed clusters of ESCs in the vicinity of SG of recipient animals 10 days after 
transplantation (Fig. 8). We were pleased with the extent of ESC migration as well as the 
number of engrafted ESCs. However, the percentage of engrafted ESCs expressing pan 
neural markers was low (less than 10%). We attributed this to (A) the short period in which 
neural induction medium was infused, and (B) the concentration of neural induction 
medium was not high enough to promote efficient neural induction, although we used a 
medium that contained 5-times higher concentrations of reagents used for our in vitro 
experiments. In order to increase the number of donor cells giving rise to neurons, we 
employ 3 approaches:  first, we will increase the length of neural induction period from 3 
days to 28 days; second, we will use a higher concentration of neural induction medium 
infused into the cochlea via osmotic pump; third, we will transplant stem cells that will have 
been incubated in neural induction medium for 2 days in vitro.  
7. Magnetic resonance imaging of ESC in the cochlea 
Monitoring transplanted cell delivery, homing, and trafficking is of the utmost importance 
for developing translational strategies. Magnetic resonance imaging (MRI) has recently 
emerged as one of the most predominant imaging modalities for tracking stem cells in live 
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animals in a noninvasive and repeated manner. To increase the resolution of images, specific 
contrast agents, such as iron-oxide nanoparticles, have been routinely used. In the present 
study, an alternative nontoxic agent, manganese chloride, was used to label only 
biologically active stem cells in host animals. Paramagnetic manganese ions (Mn2+) are 
calcium (Ca2+) analogs that are taken up by live cells through voltage-gated Ca2+ channels 
(Yamada and Yang, 2008). Thus, only cells with active Ca2+ channels are labeled with MnCl2.  
This property makes MnCl2 a unique contrast agent for functional live cell imaging.        
ESCs were labeled with 0.1 mM MnCl2 as previously described (Yamada and Yang, 2008).  
Following injection of MnCl2 labeled cells into the basal turn of the cochlea as described above, 
the animals were anesthetized with 2% isoflorane in an anesthetic chamber and maintained 
during imaging with 1-2% isoflorane delivered via face mask.  The animals were placed with 
the head centered within a custom-made birdcage head coil. Axial T1-weighted images were 
acquired using a 3D asymmetric spin-echo pulse sequence with the following parameters: TR 
= 100msec, TE = 6.5msec, 16 mm FOV, 256 x 256 matrix (Lane et al. 2005) to yield a maximum 
resolution of approximately 62 µm and minimum resolution of approximately 100 µm. Images 
were imported into Analyze (v9.0, Biomedical Imaging Resource, Mayo Clinic, Rochester, MN) 
and volume registered with the long axis of the basal turn. 
Using a 9.4T MR system, one of the highest resolution MR systems available in the USA, we 
have obtained serial coronal images of the gerbil cochlea that received transplantation of 
MnCl2-labeled ESCs. MnCl2 is a strong T1 relaxation agent which, when imaged with T1 
sensitive sequences, produces significant hyperintensity of the labeled cells.  Images were 
taken 2 days after the animal received an intra-modiolar injection of 1 million MnCl2-labeled 
ESCs.  As expected, the injected cochlea exhibited significantly hyperintense contrasts when 
compared to the uninjected cochlea in the same animal (Fig. 9). Furthermore, the 
surrounding non-labeled structure of the cochlea appeared hypointense relative to labeled 
cells. No noticeable differences in the contrast between the left and right cochleae were 
observed in the uninjected control animal.  Further optimization of imaging parameters and 
cell labeling protocols is under development. 
 
 
Fig. 9. Contiguous trans-axial Proton density weighted images of gerbil cochleae obtained 
with the 9.4T MR system.  Regions in post-transplantation cochlea (Injected Ear) exhibit 
hyperintense contrasts when compared to the control ear 
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8. Translational approaches 
Establishing a minimally-traumatic surgical technique to precisely place stem cells in the 
cochlea is a key for success in cell-based inner ear therapy.  It addresses the unmet surgical 
challenge posed by the delicate cochlear structures being located deep in the hard temporal 
bone.  Our previous studies using animal models demonstrated that transplanting stem cells 
directly into the modiolus of the gerbil basal cochlear turn yields a satisfactory degree of 
migration and engraftment (Matsuoka et al., 2006, 2007). However, our recent study using 
human cadaver temporal bones revealed that this approach would not be suitable for 
clinical applications due primarily to differences in anatomical structures between the 
rodent and human cochleae (Fritsch, 2009).  For example, the human cochlea has a much 
larger scala tympani, scala vestibuli, and modiolus. Because of these anatomical differences, 
we recently started using cadaver human temporal bones to simulate surgeries for 
transplanting stem cells into the human cochlea. The large size of the human cochlear basal 
turn modiolus has actually made translation of gerbil studies into human temporal bone 
simulation surgeries less comparable. The reason is that the modiolus is less densely packed 
with cranial nerve VIII fibers in the human compared to the gerbil. Cerebro-spinal fluid (CSF) 
is present within the internal auditory canal in that area and is pulsatile in the living human 
due to brain pulsations.  The net effect is that stem cells transplanted into the human basal turn 
modiolus are less apt to stay localized in the modiolus and more likely to either “squirt” into 
the larger internal auditory canal CSF during injection or be washed away by the pulsatile 
CSF.  These two findings give rise to an incomplete or failed stem cell placement.  For this 
reason, the investigators presently believe that the human middle turn modiolus will be the 
better target when translating gerbil studies to human subjects.  It is much more likely to retain 
the stem cell dosage injected into the modiolus.  This has been borne-out in early experiments 
on the gerbil and human cochleas with histological confirmation.  
The human middle-turn cochlea and modiolus are comparable to the human basal turn 
anatomic structures except that they are smaller and the modiolus is solidly packed with 
nerve fibers.  With injections into the middle-turn modiolus, the stem-cells are held in place 
by the gelatinous-consistency of the surrounding nerve fibers.  From that placement position 
the stem cells are free to migrate under their own guidance rather than being mechanically 
washed-away by the CSF, as in the basal turn area. The exact mechanisms for how the stem-
cells find their final location as replacement cells for originally damaged inner ear cells is 
still unknown.  However, it is felt that surgical placement directly into the modiolus, which 
is adjacent to the SG and other inner ear structures, gives them a “head start” to their final 
location; this is compared to simply injecting them into the bloodstream or CSF space. For 
this reason, the middle turn of the cochlea is especially targeted in this study relative to the 
other surgical sites. 
Unlike the basal turn, the middle turn structures cannot be simply accessed surgically by 
drilling a hole into the large promontory of the middle ear space. That basal turn surgical 
technique is commonly used every day by cochlear implant surgeons.  Rather, the middle 
turn is buried under several structures and has no “promontory” to declare it’s presence.  To 
this end, Fritsch has performed experimental surgery on the human cadaver temporal bone 
to delineate a new surgical approach to the middle turn structures: the middle turn scala 
tympani and scala vestibuli are uncovered by surgical dissection followed by injection into 
the modiolus. Ongoing studies are underway to refine the techniques; it is obvious to the 
surgeon that some manipulations of instruments are beyond the delicate touch of the 
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surgeon’s own human hands and would be better served by micro-manipulators. For 
multiple simultaneous entry sites, a small-diameter endoscope with a micromanipulator is 
currently under development (Fritsch, 2009). 
For humans undergoing implantation with a cochlear implant device, the aforementioned 
drilling into the basal turn promontory (ie: cochleostomy) is sealed using tissue autograft 
plugs to seal the cochleostomy (after device electrode placement into the cochlea). For the 
gerbil experiments so far, we have used a plastic compound to seal the needle puncture site 
in the cochlea after injection of stem cells. In humans, plastic compounds often result in 
foreign-body reaction responses resulting in giant cell granulomas. Though tissue plugs are 
used to good success in cochlear implants, they are too large for needle punctures within the 
cochlea modiolus after stem cell injections.  Purified collagen-matrix graft materials are 
being tested in animals, for tissue healing, and in human cadaver temporal bones for 
mechanical effectiveness of delivery and function. These materials are placed into the 
cadaver human temporal bone to check for extravasation into the inner ear (with 
histological confirmation) and into the gerbil with follow-up histological to check for 
healing and sealing of the cochleostomy opening.   
9. Future directions 
We plan on extending our research into 3 new directions.  First, we will continue to fill in 
gaps of our understanding of molecular mechanisms underlying Tlx3-mediated 
glutamatergic neuronal cell-fate specification.  Specifically, we aim to identify direct target 
genes for Tlx3 using a promoter array and elucidate their interactions with Tlx3 using 
chromatin immunoprecipitation and mutagenesis. We hypothesize that Tlx3, while 
activating Ngn1 transcription, triggers a counter-balance mechanism that suppresses 
GABAergic differentiation in ESC-derived neurons. Additionally, we aim to elucidate the 
epigenetic mechanisms underlying context-dependent transcriptional activation of target 
genes by Tlx3.  Identifying and characterizing Tlx3-binding proteins that can alter chromatin 
structures via acetylation and/or methylation will greatly enhance our understanding of 
extrinsic modulation of neuronal cell-type specification. Second, we will extend our 
characterization of Tlx3-expressing ESC-derived neurons. To determine whether these Tlx3-
expressing ESC-derived cells exhibit functional properties similar to those of endogenous 
SGNs and make synaptic contacts with their targets after neural induction, we will evaluate 
(A) glutamate release, (B) synaptic transmission, (C) target innervation and (D) 
electrophysiological properties of Tlx3-expressing vs. non-expressing control ESC-derived 
neurons.  These studies will reveal the extent of functional and synaptic maturation of these 
transgenic neurons and provide insights into further improvements of directed 
differentiation of ESC-derived neurons. Third, we plan to further refine our surgical/MRI 
techniques and record auditory brain stem responses (ABRs) when a considerable number 
of engrafted cells expressing neural antigens are detected in the modiolas of the gerbil 
cochlea. These in vivo experiments will be instrumental in establishing translational 
strategies for successful cell-based therapy in the inner ear.  
10. Conclusion 
The present results reveal that Tlx3 confers ESCs undergoing neural differentiation with a 
glutamatergic neurotransmitter phenotype, which is accompanied by establishment of 
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proper synaptic assembly and axon outgrowth.  Furthermore, Tlx3-expressing ESCs can 
migrate towards degenerating SGNs in the inner ear of host animals and these engrafted 
stem cells can be readily visualized by MRI.  These results suggest that Tlx3-expressing 
ESCs can be used to replace damaged SGNs, which cause irreversible hearing loss in 
humans. Technical issues related to surgical approaches for safe and efficient 
transplantation of stem cells in the human cochlea, as well as, non-invasive monitoring of 
stem cell engraftment in the cochlea are discussed. 
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